Therefore, we reasoned that metastatic osteosarcoma cells in these mice are becoming resistant to α-PD-L1 mAb therapy, and that this may be due, at least in part, to suppression of T cell responses by signaling via alternative immune inhibitory receptor pathways. Here, CD274 is linked to osteosarcoma.